RA Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

RA Capital Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,629,837	Closed	-$91.9M	–	87
2024 Q1	$91.9M	Sell	2,629,837 -2,094,370	-44%	-$76.4M	1.17%	26
2023 Q4	$180M	Hold	4,724,207	–	–	2.8%	7
2023 Q3	$86.7M	Buy	4,724,207 +870,340	+23%	+$18.2M	1.71%	17
2023 Q2	$100M	Hold	3,853,867	–	–	1.89%	15
2023 Q1	$72.7M	Hold	3,853,867	–	–	1.65%	21
2022 Q4	$95M	Buy	+3,853,867	New	+$113M	1.93%	19
2021 Q1	–	Sell	-2,129,003	Closed	-$70.2M	–	100
2020 Q4	$70.2M	Hold	2,129,003	–	–	0.98%	32
2020 Q3	$38.3M	Buy	+2,129,003	New	+$38.6M	0.7%	37

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

RA Capital Management's INBX Position: Q2 2024 in Review

RA Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 2,629,837 shares — an estimated $91.9M sold.

RA Capital Management first reported a position in INBX in Q3 2020 and held it in 8 quarters. The position peaked at $180M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

RA Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
RA Capital Management sold 2,629,837 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $91.9M.
RA Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
RA Capital Management's Inhibrx, Inc. Common Stock position peaked at $180M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on RA Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.